Zobrazeno 1 - 10
of 326
pro vyhledávání: '"Harry C, Schouten"'
Autor:
Lotty Hooft, Pauline Heus, Gert P Westert, Rudolf B Kool, Suzanne E Geerlings, Janwillem Kocks, Prabath W B Nanayakkara, Tessa Rietbergen, Leti van Bodegom-Vos, Simone A van Dulmen, Eva W Verkerk, Corina de Jong, Bart J Laan, JOOST P H DRENTH, Marlies Wakkee, Aniek de Coninck, Harry C Schouten, Evelien I T de Schepper, Saskia F van Vugt, Renuka S Bindraban, Sven van Egmond, Judith J de Jong
Publikováno v:
BMJ Open Quality, Vol 11, Iss 3 (2022)
Background Reducing the overuse of care that is proven to be of low value increases the quality and safety of care. We aimed to identify lessons for reducing low-value care by looking at: (1) The effects of eight de-implementation projects. (2) The b
Externí odkaz:
https://doaj.org/article/765a305c91e64bc9b65399547acc336e
Autor:
Floor C. J. I. Moenen, Minka J. A. Vries, Patricia J. Nelemans, Katrien J. M. van Rooy, Jeannique R. R. A. Vranken, Paul W. M. Verhezen, Rick J. H. Wetzels, Hugo ten Cate, Harry C. Schouten, Erik A. M. Beckers, Yvonne M. C. Henskens
Publikováno v:
Platelets, Vol 30, Iss 1, Pp 81-87 (2019)
Light transmission aggregation (LTA) is the gold standard for the diagnosis of platelet function disorders (PFDs), but it is time-consuming and limited to specialized laboratories. Whole-blood impedance aggregometry (Multiplate) and platelet function
Externí odkaz:
https://doaj.org/article/821cf6888da845dc965608ac3a7db84b
Autor:
Claire N. Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Eric Jourdan, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srdan Verstovsek, Derek Tang, Pranav Abraham, Jennifer Lord-Bessen, Shelonitda Rose, Shien Guo, Weiqin Liao, Ruben A. Mesa
Publikováno v:
HemaSphere, Vol 5, Iss 5, p e562 (2021)
Myelofibrosis symptoms compromise health-related quality of life (HRQoL). Ruxolitinib can reduce myelofibrosis symptom severity, but many patients discontinue ruxolitinib due to loss of response or unacceptable toxicity. Fedratinib is an oral, select
Externí odkaz:
https://doaj.org/article/6f0f1cefcf9e4277a2ace7bd18ecb259
Autor:
Martine E.D. Chamuleau, Coreline N. Burggraaff, Marcel Nijland, Katerina Bakunina, Rogier Mous, Pieternella J. Lugtenburg, Daan Dierickx, Gustaaf W. van Imhoff, Joost S.P. Vermaat, Erik A.F. Marijt, Otto Visser, Caroline Mandigers, Yavuz M. Bilgin, Aart Beeker, Mark F. Durian, Bas van Rees, Lara H. Bohmer, Lidwine W. Tick, Rinske S. Boersma, Tjeerd J.F. Snijders, Harry C. Schouten, Harry R. Koene, Eva de Jongh, Nathalie Hijmering, Arjan Diepstra, Anke van den Berg, Anne I.J. Arens, Julia Huijbregts, Otto Hoekstra, Josee M. Zijlstra, Daphne de Jong, Marie José Kersten
Publikováno v:
Haematologica, Vol 105, Iss 12 (2019)
Patients with MYC-rearrangement positive large B-cell lymphoma (MYC+ LBCL) have an inferior prognosis following standard first-line therapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) as compared to patients
Externí odkaz:
https://doaj.org/article/9e884d781be241e5a7a40641a15b0ac5
Autor:
Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph A. Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud D. Aljurf, Jean-Yves Cahn, Mitchell S. Cairo, Corey S. Cutler, Shatha Farhan, Usama Gergis, Gregory A. Hale, Shahrukh K. Hashmi, Yoshihiro Inamoto, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Margaret L. MacMillan, David I. Marks, Hideki Nakasone, Maxim Norkin, Muna Qayed, Olle Ringden, Harry C. Schouten, Kirk R. Schultz, Melhem M. Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F. Verdonck, Robert Peter Gale, Betty K. Hamilton, Navneet S. Majhail, Alison W. Loren
Publikováno v:
Blood Advances, Vol 2, Iss 9, Pp 1022-1031 (2018)
Abstract: Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with
Externí odkaz:
https://doaj.org/article/eb6763f7bff54d2a9f6cf9c3ac09fd21
Autor:
Annalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, Boris Afanasyev, Jan J. Cornelissen, Ahmet Elmaagacli, Maija Itälä-Remes, Didier Blaise, Ellen Meijer, Yener Koc, Noel Milpied, Harry C. Schouten, Nicolaus Kroeger, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background Experience using post-transplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation (HSCT) from matched sibling donors (MSD) or unrelated donors (UD) is limited and wit
Externí odkaz:
https://doaj.org/article/2d1c8d7b81804ce4b88caa3dea2f1dc3
Autor:
Bianca Wauben, Nicole C. van Yperen, Marjolein W.M. van der Poel, Sebastian Köhler, Marleen M.J. van Greevenbroek, Harry C. Schouten
Publikováno v:
Journal of Clinical Epidemiology. 148:10-16
The MOSA study (Maastricht Observational study of late effects after Stem cell trAnsplantation) aims to study the prevalence of adverse health effects in hematopoietic stem cell transplantation (HCT) survivors compared to a matched cohort, representi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d99092306e40af6117b8dbf4a72e731
https://doi.org/10.1016/j.jclinepi.2022.03.012
https://doi.org/10.1016/j.jclinepi.2022.03.012
Autor:
Marie Robin, Sylvie Chevret, Linda Koster, Christine Wolschke, Ibrahim Yakoub-Agha, Jean Henri Bourhis, Patrice Chevallier, Jan J. Cornelissen, Péter Reményi, Johan Maertens, Xavier Poiré, Charles Craddock, Gérard Socié, Maija Itälä-Remes, Harry C. Schouten, Tony Marchand, Jakob Passweg, Didier Blaise, Gandhi Damaj, Zubeyde Nur Ozkurt, Tsila Zuckerman, Thomas Cluzeau, Hélène Labussière-Wallet, Jörg Cammenga, Donal McLornan, Yves Chalandon, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 104, Iss 6 (2019)
The use of antihuman T-lymphocyte immunoglobulin in the setting of transplantation from an HLA-matched related donor is still much debated. Acute and chronic graft-versus-host disease are the main causes of morbidity and mortality after allogeneic he
Externí odkaz:
https://doaj.org/article/78605200dfee49f8a66bffba2fce5fe6
Autor:
Steven Z. Pavletic, Mary M. Horowitz, Daniel J. Weisdorf, John R. Wingard, Leo F. Verdonck, Harry C. Schouten, Stephen R. Spellman, Stella Santarone, Effie W. Petersdorf, Stephanie J. Lee, Thomas R. Klumpp, Madan H. Jagasia, David A. Jacobsohn, Luis M. Isola, Roger Herzig, Robert P. Gale, Mary E. Flowers, Corey S. Cutler, Mitchell S. Cairo, Jean-Yves Y. Cahn, Brian J. Bolwell, Joseph H. Antin, Alvaro Urbano-Ispizua, Michael Hemmer, Anna Hassebroek, John P. Klein, Mukta Arora, Michael Boyiadzis
Supplemental Table 1. Multivariate analysis of late relapse, transplant-related mortality, overall survival after HCT for each disease (AML, ALL, CML, MDS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8b6bb0ec143b555d4baa55cd9d07bc
https://doi.org/10.1158/1078-0432.22459019.v1
https://doi.org/10.1158/1078-0432.22459019.v1
Autor:
Arnon Nagler, Mohamad Mohty, Eliane Gluckman, Bipin N. Savani, Didier Blaise, Noel Milpied, Harry C. Schouten, Marco R. De Groot, Dietger Niederwieser, Henrik Sengeloev, Ellen Meijer, Jan J. Cornelissen, Annalisa Ruggeri, Myriam Labopin, Frédéric Baron
Purpose: We assessed the impact of donor type in acute myeloid leukemia (AML) patients transplanted with 2 Gy total body irradiation (TBI)-based nonmyeloablative conditioning regimen.Patients and Methods: Data from 1,715 adult patients, with AML in C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8631650a33b2bf4cc404c0a19523a550
https://doi.org/10.1158/1078-0432.c.6527607.v1
https://doi.org/10.1158/1078-0432.c.6527607.v1